Relay Therapeutics
RLAY
RLAY
161 hedge funds and large institutions have $2.76B invested in Relay Therapeutics in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 70 increasing their positions, 29 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
161
Holders Change
+13
Holders Change %
+8.78%
% of All Funds
2.78%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
31
Increased
70
Reduced
29
Closed
18
Calls
$7.22M
Puts
$1.78M
Net Calls
+$5.43M
Net Calls Change
-$449K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28.2M |
| 2 |
AG
Artal Group
Luxembourg
|
+$16.9M |
| 3 |
CC
Casdin Capital
New York
|
+$13.8M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$13.5M |
| 5 |
Goldman Sachs
New York
|
+$10.4M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$31.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$30.8M |
| 3 |
State Street
Boston,
Massachusetts
|
-$24.8M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$16.5M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$11.2M |
